AGAP14P

Across TCGA pan-cancer cohorts, AGAP14P RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated AGAP14P data layer compared with 3 for mutation status.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher AGAP14P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated AGAP14P expression acts as an unfavorable survival marker, although some lineages such as READ and SKCM show a favorable association.

ACC, KIRC, and UVM are the cancer types where AGAP14P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Median	All	0.421	0.744	<.001	99	view →
KIRC	DFS	Quartile	III,IV	0.302	0.610	<.001	42	view →
UVM	OS	Median	All	0.468	1.000	.004	33	view →
READ	DFS	Tertile	III,IV	1.000	0.621	.001	29	view →
SKCM	DFS	Median	IV	0.633	0.072	.012	16	view →
THCA	DFS	Median	IV	0.473	0.787	.013	16	view →
CHOL	DFS	Quartile	All	0.791	0.171	.006	12	view →
UCS	OS	Tertile	II,III,IV	0.738	0.345	.012	12	view →
LUAD	OS	Median	IV	0.337	0.756	.021	12	view →
KICH	OS	Median	II,III,IV	0.808	0.972	.016	11	view →
BLCA	OS	Quartile	IV	0.766	0.501	.016	7	view →
HNSC	OS	Median	IV	0.500	0.334	.017	7	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

AGAP14P–ACC (DFS)

Open the ACC breakdown →